Edgewell Personal Care (EPC)

NYSE Consumer Staples Household Products S&P SmallCap 600
$27.99
-0.57 (-2.00%)
Close of Nov 06, 2026 · end-of-day data
SMA 50SMA 2005Y/10Y use weekly candles (10/40-week averages)

Performance

price return
1W-2.0%
1M+0.9%
3M+0.0%
6M+31.7%
YTD+64.2%
1Y+45.9%
3Y-19.9%
5Y-20.0%

Key statistics

Full financials →
Market cap$1.3B
P/E (TTM)—
EPS (TTM, diluted)$-1.98
P/S0.57
P/B0.88
EV / EBITDA21.4
Revenue (TTM)$2.24B
Revenue growth+11.6%
Net margin-4.2%
ROE-6.4%
Debt / equity0.85
FCF yield4.1%
Dividend yield2.14%
Payout ratio—
Beta (1Y)0.32
Volatility (1Y)43.2%
52-week range$15.73 – $30.36
Avg volume (50D)537.24K

Revenue & net income — last 8 quarters

Statements →

Chart pattern: Triple Bottom (weekly)

Forming
EPC Triple Bottom chart

Trigger $29.95 (+7.0% away). Details →

Sep 23, 8:15 AM ET

Edgewell Personal Care names LaTanya Langley Chief Administrative and Legal Officer, effective Oct. 1

Neutral leadership Written later 5.02

Edgewell Personal Care said LaTanya Langley will become Chief Administrative and Legal Officer and Corporate Secretary effective October 1, 2026, and will leave her Chief People Officer role on the same date. The filing states there are no changes to her compensation tied to these role changes.

  • Role change effective October 1, 2026, determined by the company on September 17, 2026
  • Langley will no longer serve as Chief People Officer as of October 1, 2026
  • No change to Langley's compensation in connection with the role changes
Read the filing on SEC.gov ↗
Aug 5, 6:10 AM ET

Edgewell Q3 sales rise 1.7% to $570.1M; GAAP EPS falls to $0.26; outlook narrowed

Mixed earnings Written later 2.02

Edgewell reported fiscal third-quarter 2026 results for the quarter ended June 30, 2026. Net sales rose 1.7% to $570.1 million and adjusted EPS was flat at $0.72, while GAAP diluted EPS fell to $0.26 from $0.46. The company narrowed its full-year adjusted EPS range to $1.80 to $2.00 with the midpoint unchanged, but lowered its GAAP EPS outlook to flat to $0.20 and raised its expected restructuring-related charges to about $92 million.

  • Third-quarter net sales were $570.1 million, up 1.7%; organic net sales rose 1.1%, with North America up 3.0% and International down 1.4%.
  • Adjusted EPS was $0.72, unchanged from the prior year; GAAP diluted EPS was $0.26 versus $0.46.
  • Full-year adjusted EPS outlook narrowed to $1.80 to $2.00 from $1.70 to $2.10; GAAP EPS outlook lowered to flat to $0.20 from flat to $0.40.
  • The Board declared a quarterly dividend of $0.15 per share, payable October 8, 2026 to holders of record on September 9, 2026.
Read the filing on SEC.gov ↗
May 26, 1:19 PM ET

Edgewell Personal Care names Anthony Freve Chief Supply Chain Officer, effective June 1

Neutral leadership Written later 5.027.01

Edgewell Personal Care said Paul R. Hibbert will leave his role as Chief Supply Chain Officer effective June 1, 2026, and that Anthony Freve will succeed him in that role on the same date. The filing does not describe the reasons for the change, and the company is not reporting financial figures in this filing.

  • Paul R. Hibbert will no longer serve as Chief Supply Chain Officer, effective June 1, 2026; the company made this determination on May 20, 2026.
  • Hibbert is eligible for payments and benefits under the Company's Executive Severance Plan.
  • Anthony Freve will join Edgewell as Chief Supply Chain Officer, effective June 1, 2026, according to an announcement on May 26, 2026.
Read the filing on SEC.gov ↗
May 6, 6:14 AM ET

Edgewell Q2 adjusted EPS falls to $0.60; GAAP EPS outlook cut to flat-$0.40

Mixed earnings Written later 2.02

Edgewell reported fiscal second-quarter 2026 results, excluding the divested Feminine Care business. Net sales rose 0.6% to $519.5 million, but organic net sales fell 2.4% and adjusted EPS declined to $0.60 from $0.69. The company cut its full-year GAAP EPS outlook to flat to $0.40 from $0.55 to $0.95 because of higher restructuring and legal costs, while keeping its adjusted EPS outlook at $1.70 to $2.10.

  • Q2 net sales $519.5 million, up 0.6%; organic net sales down 2.4%
  • GAAP diluted EPS $0.09 vs. $0.43 a year earlier; adjusted EPS $0.60 vs. $0.69
  • FY2026 GAAP EPS outlook lowered to flat to $0.40; expected restructuring charges raised to about $90 million from $65 million
  • Quarterly dividend of $0.15 per share declared, payable July 9, 2026 to holders of record June 10, 2026
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Recent SEC filings

EDGAR ↗

Prices are end-of-day and split-adjusted. Financial data from Edgewell Personal Care's SEC XBRL filings. Not investment advice.